17 Oct 2014 07:00
Collagen Solutions Plc
(the "Company" or the "Group")
Funded Research Collaboration with Jellagen
Collagen Solutions plc (AIM: COS), the developer and manufacturer of medical grade collagen components for use in regenerative medicine, medical devices and in-vitro diagnostics, announces that it will be collaborating with Jellagen Pty Ltd ('Jellagen') as part of a Small firms' Merit Award for Research and Technology ('SMART') grant to improve the production of medical grade collagen derived from jellyfish.
The SMART funding from Innovate UK amounts to almost £100k and will help Jellagen improve their product quality as well as the efficiency of collagen extraction from jellyfish. This funding will also be used to investigate, alongside Collagen Solutions, Swansea University's Centre for Nano Health and University College London ('UCL'), the utilisation of jellyfish derived, medical grade, Type II and Type V collagen for the fabrication of various medical devices. This will include the generation of specific biological data on the use of this improved collagen for applications in bone grafts
Stewart White, CEO of Collagen Solutions commented: "We require access to consistent supplies of medical grade collagen derived from jellyfish and therefore made a strategic investment in Jellagen when it was founded. We see this as a reliable and renewable source of novel medical grade collagen which we can then help to fabricate into potential medical products. This development work will be carried out with the support of our in-house teams in San Diego and Glasgow. The SMART funding will allow Collagen Solutions to provide further support in order to develop novel commercial forms of Jellyfish collagen for Jellagen."
Enquiries:
Collagen Solutions Plc |
| |
David Evans, Chairman | Tel: 07740 084 452 | |
Stewart White, CEO | Tel: 0141 558 2008 | |
|
| |
Zeus Capital (Nominated Adviser and Broker) |
| |
Ross Andrews / John Depasquale (Corporate Finance) | Tel: 0161 831 1512 | |
Dominic Wilson (Institutional Sales) | Tel: 020 7533 7727 | |
|
| |
Walbrook PR Ltd | Tel: 020 7933 8780 or collagen@walbrookpr.com | |
Mike Wort | Mob: 07900 608 002 | |
Anna Dunphy | Mob: 07876 741 001 | |
Notes to Editors:
About Jellagen:
Jellagen was founded in May 2013 and offers the full spectrum of jellyfish derived collagen proteins being the first provider of pharma grade, GMP, and ISO certified Type II and Type V jellyfish collagen. This collagen is a raw material for fabrication into devices for regenerative medicine and the cell culture market.
Collagen is used in the manufacture of biomaterials due to its ability to form strong fibres and is used in many forms (such as gels, scaffolds and membranes) for a number of medical applications ranging from wound care and cartilage repair through to bone grafts.